Page last updated: 2024-08-23

1-deoxynojirimycin and lactacystin

1-deoxynojirimycin has been researched along with lactacystin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Androlewicz, MJ; Wang, Y	1
Beller, M; Giese, AK; Gläser, A; Lukas, J; Pockrandt, AM; Pohlers, S; Rolfs, A; Runge, F; Seemann, S; Sharif, M; Zheng, C	1

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and lactacystin

Article	Year
Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase. Biochemical and biophysical research communications, 2000, Apr-29, Volume: 271, Issue:1 Topics: 1-Deoxynojirimycin; Acetylcysteine; Alkaloids; Animals; Antigens; Calcium-Binding Proteins; Calnexin; COS Cells; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Enzyme Inhibitors; Glucosidases; Humans; Indolizines; Mannosidases; Models, Biological; Monophenol Monooxygenase; Precipitin Tests; Time Factors	2000
Enzyme enhancers for the treatment of Fabry and Pompe disease. Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:3 Topics: 1-Deoxynojirimycin; Acetylcysteine; alpha-Galactosidase; alpha-Glucosidases; Ambroxol; Bezafibrate; Enzyme Activators; Fabry Disease; Gene Expression; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Leupeptins; Lysosomes; Pioglitazone; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Recombinant Proteins; Thiazolidinediones; Transfection	2015

Article

Year

Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase.

Biochemical and biophysical research communications, 2000, Apr-29, Volume: 271, Issue:1

Topics: 1-Deoxynojirimycin; Acetylcysteine; Alkaloids; Animals; Antigens; Calcium-Binding Proteins; Calnexin; COS Cells; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Enzyme Inhibitors; Glucosidases; Humans; Indolizines; Mannosidases; Models, Biological; Monophenol Monooxygenase; Precipitin Tests; Time Factors

2000

Enzyme enhancers for the treatment of Fabry and Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:3

Topics: 1-Deoxynojirimycin; Acetylcysteine; alpha-Galactosidase; alpha-Glucosidases; Ambroxol; Bezafibrate; Enzyme Activators; Fabry Disease; Gene Expression; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Leupeptins; Lysosomes; Pioglitazone; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Recombinant Proteins; Thiazolidinediones; Transfection

2015